Calithera Biosciences Raises $40 Million
Calithera Biosciences, a South San Francisco-based developer of oncology therapeutics, has raised $40 million in Series A funding. Morgenthaler Ventures led the round, and was joined by U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital.
8 July 2010•4 mins read
